Tyra Biosciences, Inc. (TYRA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.57B |
| Enterprise Value | 1.5B |
| P/E Ratio | -14.62 |
| PEG Ratio | 0.54 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 5.08 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -13.91 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.32 |
| Return On Equity | -0.43 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -119.4M |
| Net Income | -119.95M |
| Diluted EPS | -2.01 |
Balance Sheet
| Total Cash | 383.47M |
| Total Cash/Share | 6.21 |
| Total Debt | 5.7M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 20.49 |
| Book Value Per Share | 6.28 |
Price History
| 52-Week Change | 207.43 |
| 52-Week High | 40.65 |
| 52-Week Low | 9.96 |
| Moving Average 50 Days | 30.63 |
| Moving Average 200 Days | 28.87 |
Statistics
| Average Volume | 812,909 |
| Shares Outstanding | 59.47M |
| % Held by Institutions | 110.63 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
